Biotechnological description of technologies for obtaining of antigens of Candida genus fungi

Автор(и)

  • М Rybalkin Natioanl University of Pharmacy,

Ключові слова:

candidiasis, antigen, vaccine, immunity

Анотація

To develop the vaccine against candidal infection the various biotechnological methods for obtaining antigens of Candida genus fungi have been considered in the article. To obtain antigens for the prevention and treatment of candidiasis researchers use different types and parts of fungi of the genus Candida. Methods of preparation of antigens also vary widely including chemical, physical and physico-chemical techniques. Of all possible variants development and research of a dead and subunit vaccine based on C. albicans and C. tropicalis fungi that are the main causative agents of candidiasis have been chosen for further study.

Посилання

Borsch S. K. Combined use of antifungal agents and probiotics combustiology for treatment and prevention of candidiasis and irritable bowel syndrome / S. K. Borsch, T. R. Maslyak // Current gastroenterology. - 2011. - № 4. - P. 30-39.

Yelinov N. P. Candida species and candidemia. State of the problem / N. P. Yelinov // Problems of medical mycology. – 2001. - V. 3, № 1. - P. 4-15.

Kapustina O. A. Species composition and biological properties of fungi of the genus Candida isolated from various habitats of the human body / O. A. Kapustina, L. E. Logacheva, O. L. Kartashova // Proceedings of the Orenburg state agrarian university. - 2009. - V. 4, № 24. - S. 179-181.

Participation candida spp. in the formation of inflammatory diseases of different localization / A. P. Godovalov, G. P. Ozhgibesov, L. P. Bykova, E. A. Nikulina // Problems of medical mycology. - 2008. - T. 10, № 2. - P. 34-36.

Anaul Kabir M. Candida infections and their prevention / M. Anaul Kabir, Zulfiqar Ahmad // ISRN Preventive Medicine. – 2013. - P. 1-13.

Odds F. C. CHROMagar Candida, a new differential isolation medium for presumptive identification of clinically important Candida species / F. C. Odds, and R. Bernaerts // Clin. Microbiol. - 1994. - № 32. – P. 1923-1929.

Culture and Identification of Candida albicans from vaginal ulcer and separation of enolase on SDS-PAGE // P. Saravana Bhavan, R. Rajkumar, S. Radhakrishnan, C.Seenivasan, S. Kannan / Interer journal of biology. 2010. – V. 2, № 1. – P. 84–93.

Identification of Candida albicans by using different culture medias and its association in potentially malignant and malignant lesions // Sonal Saigal, Ankur Bhargava, S. K. Mehra, Falguni Dakwala / Contemp Clin Dent. – 2011. - V. 2, № 3. – P. 188–193.

Brown G. D. Innate antifungal immunity: the key role of phagocytes / G. D. Brown // Annu Rev Immunol. – 2011. – Vol. 29. – P. 1–21.

LeibundGut-Landman, S. Immunity to fungi / S. LeibundGut-Landman, M. Wutrich & T. Hohl // Curr. Opin. Immunol. – 2012. – Vol. 24, № 2. – P. 449–458.Miceli E M. H. Emerging opportunistic yeast infections / M. H. Miceli, J. A. Díaz and S. A. Lee // The Lancet Infectious Diseases. - 2011. - V. 11, № 2. - P. 142–151.

The changing epidemiology of healthcare-associated candidemia over three decades / D. Diekema, S. Arbefeville, L. Boyken, J. Kroeger & M. Pfaller // Diagn. Microbiol. Infect. Dis. – 2012. - № 73. – P. 45–48.

Zhukova N. V. Modern vaccines: characterization and classification / N. V. Zhukova, I. M. Krivosheeva // Krimska journal is therapeutic. - 2013. - № 2. - P. 99-104.

Maluy V. P. Vaccines prevention: general and the private questions, problems and prospects / V. P. Maluy // Clinical immunology. Allergology. Infectology. - 2009. - V. 23, № 4. - P. 5-22.

Patent 2445109 The Russian Federation, МПК7A 61 K 36/062, A 61 K 47/02, C 12 N 1/14. Associated vaccine against cutaneous candidiasis carnivores, a method of manufacturing associated vaccine against cutaneous candidiasis carnivorous way of prevention and treatment of cutaneous candidiasis carnivores. A. M. Litvinov, N. A. Apanasenko. (RF). – 2010127796/10; stated 07.07.2010; published 07.07.2010.

Petrov P. V. Immunogens and new generation vaccine / P. V. Petrov, R. M. Khaitov - M.: GEOSTAR-Medicine, 2011. – 608 p.

Candida albicans vaccines / Aditi Grover, B. S. Bhandari, Nishant Rai, Pramesh C Lakhera // Biotechnology International. – 2010. – Vol. 3, № 1. – P. 4-17.

Immune responses induced by heat-killed Saccharomyces cerevisiae: a vaccine against fungal infection / M. Liu et al. // Vaccine. – 2011. – V. 29. – P. 1745–1753.

Cassone A. Fungal vaccines: real progress from real challenges / A. Cassone // Lancet Infect dis. – 2008. – Vol. 8. – P. 114-124.

Cassone A. Development of vaccines for Candida albicans: fighting a skilled transformer / A. Cassone // Nature Reviews Microbiology. – 2013. – V. 11. P. 884–891.

Han Y. Comparison of two Candida mannan vaccines: the role of complement in protection against disseminated candidiasis / Y. Han, K. Y. Rhew // Arch. Pharm. Res. – 2012. - № 35. – P. 2021–2027.

Synthetic glycopeptide vaccines combining β-mannan and peptide epitopes induce protection against candidiasis / H. Xin, S.Dziadek, D. R. Bundle, J.

E.Cutler //ProcNatlAcadSci U S A. – 2008. - № 105. –Р. 13526-13531.

Cutler J. E. Advances in combating fungal diseases: vaccines on the threshold / J. E. Cutler, G. S. Deepe, B. S. Klein // Nat Rev Microbiol. – 2007. – Vol. 5. – P. 13–28.

David A. D'Argenio A decade of vaccines: integrating immunology and vaccinology for rational vaccine design / A. D'Argenio David, B. Wilson Christopher // Immunity. – 2010. – V. 33, № 4. –P. 437-440.

Host defense pathways against fungi: the basis for vaccines and immunotherapy / Carvalho, A. et al. // Front. Microbiol. – 2012. – V. 3. – P. 1–9.

Nabel G. J. Designing Tomorrow’s Vaccines / Nabel G. J. // N Eng J Med. – 2013. – V. 6, № 368. –Р. 551-60.

Kashkina M. A. Influence of yeast polysaccharides on immune reactivity: author. diss. ... candidate. biol. science / M. A. Kashkina - Leningrad, 1974. – 19 p.

Ruth Ashbee H. The yeast handbook / H. Ruth Ashbee, Elaine M. Bignell - Springer. - 2010. - 365 P.

Janelle M. Hare Sabouraud agar for fungal growth / M. Hare Janelle // Laboratory Protocols in fungal biolodgy. – 2013. - P. 211-216.

Combination vaccines // A. G.Skibinski David, C. Barbara Baudner, Singh Manmohan, T. O.’Hagan Derek / Glob Infect Dis. – 2011. – V. 3, № 1. –P. 63–72.

##submission.downloads##

Як цитувати

Rybalkin М. (2020). Biotechnological description of technologies for obtaining of antigens of Candida genus fungi. Анали Мечниковського Інституту, (2), 20–24. вилучено із https://journals.uran.ua/ami/article/view/207923

Номер

Розділ

Огляди